|1.||Miyazaki, Ikuko: 3 articles (01/2008 - 01/2003)|
|2.||Asanuma, Masato: 3 articles (01/2008 - 01/2003)|
|3.||Cavalieri, Ercole L: 2 articles (12/2011 - 08/2011)|
|4.||Zahid, Muhammad: 2 articles (12/2011 - 08/2011)|
|5.||Ogawa, Norio: 2 articles (10/2004 - 01/2003)|
|6.||Saeed, Muhammad: 1 article (12/2011)|
|7.||Yang, Li: 1 article (12/2011)|
|8.||Rogan, Eleanor: 1 article (12/2011)|
|9.||Beseler, Cheryl: 1 article (12/2011)|
|10.||Rogan, Eleanor G: 1 article (08/2011)|
|1.||Parkinson Disease (Parkinson's Disease)
03/01/2008 - "Proteomic analysis of rat brain mitochondria following exposure to dopamine quinone: implications for Parkinson disease."
12/01/2011 - "Formation of dopamine quinone-DNA adducts and their potential role in the etiology of Parkinson's disease."
01/01/2010 - "Oxidized metabolites of dopamine known as dopamine quinone derivatives are thought to play a pivotal role in the degeneration of nigrostriatal dopaminergic neurons in Parkinson's disease. "
12/14/2007 - "An abnormal accumulation of cytosolic dopamine resulting in reactive oxygen species and dopamine-quinone products may play an important role in the rather selective degeneration of substantia nigra pars compacta (SNc) dopaminergic neurons in Parkinson's disease. "
10/01/2005 - "In this work, we demonstrate that oxidized products of dopamine (neurotoxic dopamine quinone), a neurotransmitter involved in Parkinson's disease, promote tau polymerization. "
|2.||Parkinsonian Disorders (Parkinsonism)
|4.||Neurotransmitter Agents (Neurotransmitter)
|5.||Reactive Oxygen Species (Oxygen Radicals)
|6.||Monophenol Monooxygenase (Tyrosinase)
|8.||Nitric Oxide (Nitrogen Monoxide)
|10.||Levodopa (L Dopa)